Pharmaceuticals, Medical Cannabis, Telemedicine, Digital Health, D2C, Compounding Pharmacy, HealthTech, API Distribution
MediCropsAE Group has raised $4.5M in total funding. The most recent round was Series A. The last funding was announced in December 2024.
MediCropsAE Group's investors include Ivan Mestrangelo.
MediCropsAE Group is headquartered in Pfaffikon, Switzerland.
Pharmaceuticals, Medical Cannabis, Telemedicine, Digital Health, D2C, Compounding Pharmacy, HealthTech, API Distribution
MediCropsAE Group is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MediCropsAE Group — Funding & Investors." VCBacked, December 17, 2024, https://www.vcbacked.co/company/medicropsae-group. Accessed September 10, 2026.
VCBacked. (2024). MediCropsAE Group — Funding & Investors. Retrieved September 10, 2026, from https://www.vcbacked.co/company/medicropsae-group
{{cite web |title=MediCropsAE Group — Funding & Investors |url=https://www.vcbacked.co/company/medicropsae-group |website=VCBacked |access-date=September 10, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated